SCHEMBL372841

SCHEMBL372841

CCCCCN1C=CN(C)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.35
EBP Q15125 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
PTGS1 P23219 3/20 0.33
PTGS2 P35354 3/20 0.33
MGLL Q99685 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
FAAH O00519 1/20 0.33
GNAI3 P08754 1/20 0.32
GNAO1 P09471 1/20 0.32
GNAI1 P63096 1/20 0.32
DNM1 Q05193 2/20 0.32
TBXAS1 P24557 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
PABPC1 P11940 1/20 0.31
APOBEC3A P31941 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL294133 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL4061744 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL372301 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL4066620 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL4066198 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL92757 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL2890409 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL5305365 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
Fluoride SCHEMBL1897237 0.98 GUSB (0.34) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL572164 0.98 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122085568-A Ion gel electrolyte composition capable of being subjected to room-temperature in-situ spontaneous polymerization, electrolyte and application 2026-05-26 CN claimed
EP-3251133-B1 WIDE OPERATING TEMPERATURE RANGE (0° TO 275°C) ULTRACAPACITOR FASTCAP ULTRACAPACITORS LLC (US) 2025-12-24 EP claimed
EP-4650498-A1 FLUID CONTACTING DEVICE Aurotec GmbH (AT) 2025-11-19 EP claimed
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS nanoSUR LLC 2025-04-10 US claimed
CN-119324231-A Pluggable semi-metal-based non-sacrificial electrode and application thereof 南京理工大学 2025-01-17 CN claimed
EP-4470972-A1 PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE SPECIALTY OPERATIONS FRANCE (FR) 2024-12-04 EP claimed
CN-119059497-A Process for the production of onium salts of bis (fluorosulfonyl) imide 法国特种经营公司 2024-12-03 CN claimed
CN-118047908-A Hydrophobic ion elastomer and preparation method thereof 福建理工大学 2024-05-17 CN claimed
CN-113346058-B Method for preparing bimetallic sulfide and carbon composite under ion gel system 大连理工大学 2024-05-17 CN claimed
CN-114315728-B Imidazole ionic liquid and application thereof in alcoholysis polymerization of 2, 5-furandicarboxylic acid ester 中国科学院大连化学物理研究所 2024-04-19 CN claimed
EP-1789160-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2007-05-30 EP claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
WO-2006048171-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2006-05-11 WO claimed
EP-1649894-A2 Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials L'OREAL (FR) 2006-04-26 EP claimed
WO-2006029788-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2006-03-23 WO claimed
WO-2006027069-A1 METHOD FOR PRODUCING HETEROCYCLIC QUATERNARY AMMONIUM AND/OR GUANIDINIUM COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-03-16 WO claimed
WO-2006027070-A1 METHOD FOR THE PRODUCTION OF HETEROCYCLIC QUATERNARY AMMONIUM COMPOUNDS AND/OR GUANIDINE COMPOUNDS HAVING HIGH PURITY BASF AKTIENGESELLSCHAFT (DE) 2006-03-16 WO claimed
EP-1362572-A1 Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment L'OREAL (FR) 2003-11-19 EP claimed
WO-2003076366-A2 A METHOD FOR PREPARING ORGANIC FLUOROCOMPOUNDS CHEMTECH RESEARCH INCORPORATION (KR) 2003-09-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS NSUN2, NSUN3, RNGTT GUSB 2287/4885EBP 2701/4885SIGMAR1 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.